Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MELITAC 12.1 Peptide Vaccine |
Synonyms | |
Therapy Description |
MELITAC 12.1 peptide vaccine is a cancer vaccine that contains both melanoma peptides and helper peptides, which may stimulate an immune response against melanoma tumor cells (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MELITAC 12.1 Peptide Vaccine | MELITAC 12.1 peptide vaccine is a cancer vaccine that contains both melanoma peptides and helper peptides, which may stimulate an immune response against melanoma tumor cells (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT01961115 | Phase II | Epacadostat MELITAC 12.1 Peptide Vaccine | INCB024360 and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma | Completed | USA | 0 |